JILLIAN KINZEL: Open Payments
NPI 1861769572 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 63 payments from 28 companies in 2025. Trend: 2023 $1,262 · 2024 $1,407 · 2025 $1,258
Food & beverage: $1,258
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $215 |
| AstraZeneca Pharmaceuticals LP | 8 | $142 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Daiichi Sankyo Inc. | 4 | $89 |
| BeOne Medicines USA, Inc. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| PFIZER INC. | 2 | $48 |
| SpringWorks Therapeutics, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $39 |
Products named: KEYTRUDA, OPDIVO, Fabhalta, CALQUENCE, Enhertu, KISQALI, BRUKINSA, PLUVICTO.
Industry payments across AL — which companies pay providers there.
